May 16, 2014
1 min read
Save

Smartphone app associated with increased abstinence from alcohol

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In a randomized clinical trial of adults in alcohol abuse recovery, patients who received treatment as usual in addition to a smartphone with a recovery application reported a lower mean number of risky drinking days and a greater likelihood of consistent abstinence.

Participants were recently discharged from residential alcohol treatment facilities and randomized into one of two groups: a control group assigned to treatment as usual (n=179) or  treatment as usual plus a smartphone with the Addiction-Comprehensive Health Enhancement Support System (A-CHESS) application “designed to improve continuing care for alcohol use disorders” (n=170).

Participants were asked about the number of risky drinking days in the previous 30 days in surveys conducted 4, 8 and 12 months after residential treatment discharge. Researchers defined a risky drinking day as one in which four or more alcoholic drinks were consumed within 2 hours (three drinks for women).

Significantly fewer risky drinking days were reported for the intervention and follow-up periods among participants in the A-CHESS group compared with controls (P=.003). The same was true at months 4 (P=.02) and 12 (P=.03) but not month 8 (P=.10), the researchers wrote.

Participants in the A-CHESS group also had a higher likelihood of reporting abstinence in the previous 30 days, compared with controls. Though not significant at month 4, the differences were significant at months 8 (P=.04) and 12 (P=.02).

The researchers concluded that new health care apps are being developed every day and their use is becoming more popular. A-CHESS and other apps have potential value as part of an effective treatment plan for patients with alcohol use disorders and other illnesses.

Disclosures: The researchers report no relevant financial disclosures.